Skip to main content

6-K

Indivior Pharmaceuticals, Inc. (INDV)

6-K 2025-02-25 For: 2025-02-25
View Original
Added on April 10, 2026

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

________________________

Washington, D.C. 20549

_____________________

FORM 6-K

_____________________

Report of Foreign Private Issuer

Pursuant to Rule 13a-16 or 15d-16

under the Securities Exchange Act of 1934

For the month of February 2025

Commission File Number: 001-37835

________________________________________

Indivior PLC

________________________________________

10710 Midlothian Turnpike, Suite 125

North Chesterfield, Virginia 23235

(Address of principal executive office)

_______________________________

Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F

Form 20-F ☒ Form 40-F ☐

EXHIBIT INDEX

Exhibit No. Description of Exhibit
99.1 Announcement sent to the London Stock Exchange on February 25,2025,<br>titled “Holding(s) in Company”.

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

Indivior PLC
Date: February 25, 2025 /s/<br>Kathryn Hudson
Name:<br>Kathryn Hudson
Title:<br>Company Secretary

a2721y-announcement

Exhibit 99.1

TR-1: Standard form for notification of major holdings

  1. Issuer Details

ISIN

GB00BN4HT335

Issuer Name

INDIVIOR PLC

UK or Non-UK Issuer

UK
  1. Reason for Notification
An acquisition or disposal of voting rights
  1. Details of person subject to the notification obligation

Name

Morgan Stanley

City of registered office (if applicable)

Country of registered office (if applicable)

US
Name City<br>of registered office Country<br>of registered office
--- --- ---
Morgan<br>Stanley Wilmington,<br>Delaware USA
  1. Details of the shareholder

Full name of shareholder(s) if different from the person(s) subject to the notification obligation, above

City of registered office (if applicable)

Country of registered office (if applicable)

  1. Date on which the threshold was crossed or reached
20-Feb-2025
  1. Date on which Issuer notified
24-Feb-2025
  1. Total positions of person(s) subject to the notification obligation
% of voting rights attached to shares (total of 8.A) % of voting rights through financial instruments (total of 8.B 1 +<br>8.B 2) Total of both in % (8.A + 8.B) Total number of voting rights held in issuer
Resulting<br>situation on the date on which threshold was crossed or<br>reached 3.285654 2.037829 5.323483 6608428
Position<br>of previous notification (if applicable) 0.000000 0.000000 0.000000
  1. Notified details of the resulting situation on the date on which the threshold was crossed or reached

8A. Voting rights attached to shares

Class/Type of shares ISIN code(if possible) Number of direct voting rights (DTR5.1) Number of indirect voting rights (DTR5.2.1) % of direct voting rights (DTR5.1) % of indirect voting rights (DTR5.2.1)
GB00BN4HT335 4078722 3.285654
Sub Total<br>8.A 4078722 3.285654%

8B1. Financial Instruments according to (DTR5.3.1R.(1) (a))

Type of financial instrument Expiration date Exercise/conversion period Number of voting rights that may be acquired if the instrument is<br>exercised/converted % of voting rights
Right<br>of recall over securities lending agreements at any<br>time at any<br>time 654184 0.526984
Sub<br>Total 8.B1 654184 0.526984%

8B2. Financial Instruments with similar economic effect according to (DTR5.3.1R.(1) (b))

Type of financial instrument Expiration date Exercise/conversion period Physical or cash settlement Number of voting rights % of voting rights
Equity<br>Swap 10/10/2025 at any<br>time Cash 1875522 1.510845
Sub<br>Total 8.B2 1875522 1.510845%
  1. Information in relation to the person subject to the notification obligation
2. Full chain of controlled undertakings through which the voting<br>rights and/or the financial instruments are effectively held<br>starting with the ultimate controlling natural person or legal<br>entities (please add additional rows as necessary)
Ultimate controlling person Name of controlled undertaking % of voting rights if it equals or is higher than the notifiable<br>threshold % of voting rights through financial instruments if it equals or is<br>higher than the notifiable threshold Total of both if it equals or is higher than the notifiable<br>threshold
--- --- --- --- ---
Morgan<br>Stanley (Chain 1)
Morgan<br>Stanley (Chain 1) Morgan<br>Stanley Capital Management, LLC
Morgan<br>Stanley (Chain 1) Morgan<br>Stanley Domestic Holdings, LLC
Morgan<br>Stanley (Chain 1) Morgan<br>Stanley Capital Services LLC
Morgan<br>Stanley (Chain 2)
Morgan<br>Stanley (Chain 2) Morgan<br>Stanley Capital Management, LLC
Morgan<br>Stanley (Chain 2) Morgan<br>Stanley & Co. LLC
Morgan<br>Stanley (Chain 3)
Morgan<br>Stanley (Chain 3) Morgan<br>Stanley International Holdings Inc.
Morgan<br>Stanley (Chain 3) Morgan<br>Stanley International Limited
Morgan<br>Stanley (Chain 3) Morgan<br>Stanley Investments (UK)
Morgan<br>Stanley (Chain 3) Morgan<br>Stanley & Co. International plc
Morgan<br>Stanley (Chain 4)
Morgan<br>Stanley (Chain 4) Morgan<br>Stanley Capital Management, LLC
Morgan<br>Stanley (Chain 4) Morgan<br>Stanley & Co. LLC
Morgan<br>Stanley (Chain 4) Prime<br>Dealer Services Corp.
Morgan<br>Stanley (Chain 5)
Morgan<br>Stanley (Chain 5) Morgan<br>Stanley Capital Management, LLC
Morgan<br>Stanley (Chain 5) Morgan<br>Stanley Bank, N.A.
Morgan<br>Stanley (Chain 6)
Morgan<br>Stanley (Chain 6) Morgan<br>Stanley Capital Management, LLC
Morgan<br>Stanley (Chain 6) Morgan<br>Stanley Smith Barney LLC
  1. In case of proxy voting

Name of the proxy holder

The number and % of voting rights held

The date until which the voting rights will be held

  1. Additional Information

  2. Date of Completion

24-Feb-2025
  1. Place Of Completion
Mumbai